New trial - half the patients with HF have HFpEF and half them have PAH - this new trial of C-Pulse (funding or grants permitted) should have less trouble finding patients as there are only a few trials involving these preserved ejection fraction patients according to my previous post on the 04/01
"Approximately half of patients with systolic heart failure or preserved ejection fraction heart failure (HFpEF) have PAH with similar 5-year outcomes."
http://pulmonaryhypertensionnews.co...echnology-in-pulmonary-arterial-hypertension/
- Forums
- ASX - By Stock
- SHC
- SATE OF PLAY
SATE OF PLAY, page-17
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)